MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 18:35:09 04/06/2024 BST | ||
| 11.91 EUR | -1.24% |
|
| Current month | -4.81% | ||
| 1 month | -9.66% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 11.91 | -1.24% |
| 03/06/24 | 12.06 | -4.81% |
| 31/05/24 | 12.67 | -3.50% |
| 30/05/24 | 13.13 | -3.17% |
| 29/05/24 | 13.56 | +2.34% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 06:35 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ1SUA |
| ISIN | DE000DJ1SUA3 |
| Date issued | 17/05/2023 |
| Strike | 360.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.9 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.04 € |
|---|---|
| Lowest since issue | 2.98 € |
| Spread | 0.01 € |
| Spread % | 0.08% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat